These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34481008)

  • 1. Amphotericin B nanohydrogel ocular formulation using alkyl glyceryl hyaluronic acid: Formulation, characterization, and in vitro evaluation.
    Banshoya K; Fujita C; Hokimoto Y; Ohnishi M; Inoue A; Tanaka T; Kaneo Y
    Int J Pharm; 2021 Dec; 610():121061. PubMed ID: 34481008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicities and pharmacokinetics of subconjunctival injection of liposomal amphotericin B.
    Kaji Y; Yamamoto E; Hiraoka T; Oshika T
    Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):549-53. PubMed ID: 19043733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
    Usman F; Nopparat J; Javed I; Srichana T
    Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
    Zia Q; Khan AA; Swaleha Z; Owais M
    Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
    Zhou W; Wang Y; Jian J; Song S
    Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-amphotericin B nanocomplexes: a promising anti-leishmanial drug delivery system.
    Silva-Carvalho R; Leão T; Bourbon AI; Gonçalves C; Pastrana LM; Parpot P; Amorim I; Tomás AM; Gama FM
    Biomater Sci; 2022 Apr; 10(8):1952-1967. PubMed ID: 35253814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
    Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
    Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
    Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
    Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study.
    Mohamed HA; Radwan RR; Raafat AI; Ali AE
    Drug Deliv Transl Res; 2018 Feb; 8(1):191-203. PubMed ID: 29280061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the toxicity of amphotericin B by encapsulation using methoxy poly(ethylene glycol)-b-poly(l-glutamic acid-co-l-phenylalanine).
    Yang C; Xue B; Song W; Kan B; Zhang D; Yu H; Shen N; Li X; Tang Z; Chen X
    Biomater Sci; 2018 Jul; 6(8):2189-2196. PubMed ID: 29947373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B.
    Thanki K; Prajapati R; Sangamwar AT; Jain S
    Int J Pharm; 2018 Jun; 544(1):1-13. PubMed ID: 29635057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.
    Burgess BL; He Y; Baker MM; Luo B; Carroll SF; Forte TM; Oda MN
    Int J Nanomedicine; 2013; 8():4733-43. PubMed ID: 24379661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
    Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
    J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs.
    Nieto J; Alvar J; Rodríguez C; San Andrés MI; San Andrés MD; González F
    Res Vet Sci; 2018 Apr; 117():125-132. PubMed ID: 29272720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an amphotericin B micellar formulation using cholesterol-conjugated styrene-maleic acid copolymer for enhancement of blood circulation and antifungal selectivity.
    Banshoya K; Kaneo Y; Tanaka T; Yamamoto S; Maeda H
    Int J Pharm; 2020 Nov; 589():119813. PubMed ID: 32871218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.